Filter By
- Agency-Based Community Benefit (ABCB)
- Behavioral Health Reform and Investment Act Senate Bill 3 (SB3)
- Beneficiary Advisory Council (BAC)
- Child Support Services
- DDSD Provider Enrollment & Relations
- Electronic Benefits Transfer (EBT)
- Employee Abuse Registry (EAR)
- Fraud, Waste, & Abuse
- (-) Health Care Consolidation Oversight Act
- Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID)
- (-) Justice-involved Utilization of State Transitioned Healthcare (JUST Health)
- Marketplace Affordability Programs
- Medicaid Transition Premium Relief Program
- National Guard Premium Assistance
- New Mexico Medicaid Estate Recovery Program
- (-) Ordering, Referring, Prescribing Provider (ORP)
- Refugee Resettlement Program
- Rural Health Care Delivery Fund
- Small Business Health Insurance Premium Relief Initiative
- SNAP Quality Control Reviews
- State Employee Premium Assistance Program
- Sun Bucks
- Supplemental Nutrition Assistance Program (SNAP)
- Turquoise Care
All licensed hospitals and certain health care provider organizations (as defined in the legislation) proposing a merger, acquisition, or change in majority ownership/control must submit a Transaction Notice to DHI before closing.
The Health Care Consolidation Act applies to any “transaction,” defined as:
1. A merger of one hospital into another;
2. An acquisition of a hospital by another entity; or
3. A change of control of hospital ownership or real estate.
You’ll have 30 days from the initial filing to respond to any requests for missing information. A submission becomes “complete” once HCA has received all required documents, exhibits, and fees.
You can still submit written comments through the end of the comment period. All submissions—oral or written—are given equal weight in HCA’s review.
The Health Care Consolidation Oversight Act authorizes HCA to retain specialized consultants—such as actuaries, financial analysts, or legal experts—to assist with complex transaction reviews. The hospital (or transaction parties) is responsible for reimbursing the HCA’s actual costs for these services.
If HCA denies or conditions your transaction, you may request a contested-case hearing under the Uniform Licensing Act (U.L.A.) within 30 days of the decision notice.
Yes. All documents you file with HCA are treated as confidential under the Health Care Consolidation Oversight Act. If you believe certain exhibits should remain proprietary, clearly mark them “CONFIDENTIAL” and file a redacted public version.
Once your submission is complete, HCA has 120 days to issue a decision. Complex transactions or those flagged as “urgent” may follow an accelerated schedule at HCA’s discretion.
For three years following your transaction, you’ll submit yearly updates on financial performance, service volumes, community benefit activities, and any material changes—using the format HCA provides. You can fill out and submit the report form HERE. You will also need to include THIS FORM in your submission.
You can fill out the annual report form HERE. You will also need to fill out and inlcude THIS FORM in the submission.
Under the Health Care Consolidation Oversight Act, HCA may impose administrative fines on hospitals or transaction parties that knowingly violate filing requirements, proceed with a transaction without approval, or fail to comply with conditions. Fines are assessed on a per‑bed or per‑member basis (as specified in the administrative rules) and revenues are directed to the New Mexico School Fund.
You can find a full list of definitions of terms contained in the act HERE.
Yes. The Health Care Consolidation Oversight Act includes safeguards for individuals who report improper or undisclosed transactions. Whistleblowers may submit information confidentially to the HCA and are protected from retaliation. Any fine revenue collected from violations stemming from a whistleblower report also supports the School Fund.
Effective October 1, 2026, all ordering, referring, or prescribing providers must be individually enrolled in Medicaid in order for the rendering provider to be reimbursed.
Yes. All licensed behavioral health clinicians referring, ordering or prescribing services must enroll individually.
Yes. Hospital-employed or contracted clinicians who refer, order or prescribe Medicaid services must be individually enrolled.
Yes. Referring, ordering or prescribing providers contracted by Indian Health Services or a Tribal 648 must be enrolled consistent with federal and state requirements.
Yes, federal regulations require state Medicaid programs to enroll and screen providers who refer, order, or prescribe services to Medicaid members. This policy ensures compliance with those requirements.
Yes. MCO claims are subject to the same enrollment requirement. MCOs will deny claims for services rendered by non-enrolled providers effective October 1, 2026.
Yes. Even if claims are submitted under a group NPI or facility billing number, each individual referring, ordering or prescribing provider must be separately enrolled.
Yes. Individual clinicians referring, ordering or prescribing services within FQHCs and RHCs must be enrolled.
Referring, ordering and prescribing providers must enroll as a Medicaid provider. If a provider refuses to enroll, claims may be recouped. Prescriptions ordered by unenrolled pharmacists will be denied at the point of sale and members could be unable to receive needed medications.
Providers must submit an individual enrollment application through the Medicaid provider enrollment portal on YesNM.gov. Required documentation may include:
• Active NPI
• Professional license
• Disclosure information
• Screening documentation (as applicable)
Detailed instructions are available on YesNM.gov. To create a YESNM.gov account follow these
instructions.
Processing times vary depending on application completeness and required screening level. Providers are strongly encouraged to apply early to avoid payment delays
Group practices should review their roster against Medicaid enrollment records and contact Provider Enrollment for assistance at 800-299-7304 or nm.providers@hca.nm.gov.
Yes. HCA requires any participating pharmacy (on-site or community-based) to enroll and bill as a Medicaid pharmacy (separate from the medical provider) and to follow billing and claims processes, including all real-time or batched billing/claims requirements and prior authorization (PA) requirements (if applicable), that match current fee-for-service (FFS) processes.
Carceral facilities can bill for medications as medical claims when the medications are provided by the medical provider rather than dispensed directly from the pharmacy. For example, if a CDC purchases stock medications for Medication Assisted Treatment (MAT) and a qualified provider administers the treatment, the medications and any applicable services (e.g., evaluation or counseling) should be billed as a medical claim.
Facility staff may not transfer bulk medications into individual packages that do not meet state and federal prescribing standards (e.g., pill envelopes) for individuals to utilize upon release. Only medications that are labeled for a specific patient and fulfilled by a licensed pharmacist (including through a licensed onsite pharmacy) according to state and federal prescribing standards meet the medications-in-hand requirement.
No. Medicaid should only be billed for the portion of the bulk medication that is provided to the Medicaid member.
No. Medications must follow the Medicaid formulary, as identified by HCA’s preferred drug list (PDL). While updates to the PDL will be made on a regular basis, Medicaid-enrolled pharmacies should be up to date on covered drugs.